In particular, Chen et al. [100] described the mechanism by which this lncRNA acts in breast cancer cells: it is transcriptionally activated by MYC interaction with its promoter and can bind Lin28b, promoting positive regulation of both MYC and Lin28b protein. Here, LIN28B is linked to breast carcinoma.